Contraception and Infertility Flashcards
Condom type to protect against STD
Latex or Synthetic
Use with condoms would increase irritations and risk of STD/HIV
Nonoxynol-9 spermicide
What lubricant type should be avoided with latex or non-latex synthetic condoms
Oil-based lubricant
What lubricant type is recommended latex and non-latex synthetic condoms
Silicone or Water based lubricants
What is contained in foams, films, creams, suppositories, sponges and jellies
Nonoxynol-9 spermicide
Prescription only spermicide that decreases vaginal pH (3.5-4.5)
Phexxi
(Vaginal gel)
Phexxi contraindications
Vaginal rings
History of UTI
Urinary tract abnormalities
Hormonal contraceptives MOA
Inhibits FSH and LH to prevent ovulation
Alter cervical mucus to prevent sperm penetration to egg
Types of hormonal contraceptives
Progentin only (pill, injection, implant, IUD)
Estrogen/Progestin combination (pill, patch, ring)
What is required by FDA to be dispensed with oral contraceptives
Patient Package Insert
Most common estrogen formulation in hormonal combination contraceptives
Ethinyl estadiol
Most common progestin formulation in combination hormonal contraceptives
Norethindrone, Levonorgestrel, Drospirenone
Types of combinations hormonal contraceptives
Monophasic
Biphasic
Triphasic
Quadriphasic
Progestin with mild potassium sparing diuretic and anti androgenic activity
Associated with less bloating, PMS sx, weight gain and acne
Drospirenone
Progestin with low androgenic activity
Norgestimate
Desogestrel
Dienogest
Other indications for COC
Dysmenorrhea
PMS sx
Acne
Anemia
Menstural associated migraine
Peri-menopausal sx (hot flash, night sweat)
First line to regulate menses in PCOS
COC
First line to regulate dysmenorrhea and heavy bleeding in endometriosis
COC
FDA approved for endometrial pain
Elagolix (Orilissa)
(COC)
COC and Levonorgestrel IUD approved for heavy menstural bleeding
Natazia (COC)
Mirena (Levonorgestrel IUD)
Approved for heavy bleeding associated with uterine fibroid but not a contraceptive
Oriahnn (estradiol, norethindrone, elagolix)
Nonhormonal oral formulation of TXA for menorrhagia
Lysteda
(COC)
aka mini pill
Progestin Only Pill (POP)
MOA of action POP
Suppresses ovulation
Thickens cervical mucus
Thins endometrium
28 days active pills
Indication of use for POP
Breastfeeding (estrogen reduces milk production)
Migraine prophylaxis
Migraines with aura (estrogen increases the of stroke)
Any contraindication to estrogen
How soon can POP be initiated post-partum
3-6 weeks
(Estrogen increases risk of thrombosis post-partum)
What is the timing of administration for POP
Take within 3hrs of scheduled time
How is the patch (CHC) different from COC
Higher systemic estrogen content
Avoid with COC patch
Increased clotting risk
> 35 y.o and smokes
When is patch less effective
Wt > 193 lbs (Xulane)
BMI > 30 (Twirla)
How often are vaginal rings (CHC) inserted
Once monthly
Injectable contraceptive
Depo-Provera
Depo-SQ Provera 104
Depo-Provera dosing
IM 150mg or SC 104mg every 3 months
What is an important counseling point for depot shots for women who wants quick return of fertility following discontinuation
Most females will remain amenorrheic for 12 months (prolonged return of fertility)
How are most COC or CHC dosed
28 days supply
3 wks of active drug and 1 wk of inactive drug (placebo, iron, folate)
Bleeding will occur during the hormone free week (aka week 4)
Extended cycle COC
84 days of active drug and 7 days of inactive drug or low dose estrogen
Bleeding occurs every 3 months rather than monthly
Clinical pearl of continuous use of COC without placebo
Continous use can suppress menses altogether
Difficult to predict if pregnancy has occured
Risk of breakthrough bleeding or spotting usually resolves after 3-6 months
Less anemia and menstrual migraines
Continous COC without placebo week
Amethyst